Manel Esteller Selected Research

Histones (Histone)

1/2020	Epigenetic Awakening of Viral Mimicry in Cancer.
1/2018	Epigenetic control of influenza virus: role of H3K79 methylation in interferon-induced antiviral response.
11/2017	Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats.
9/2015	KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.
6/2015	Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
1/2015	Barcelona Conference on Epigenetics and Cancer: 50 years of histone acetylation.
1/2014	Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.
9/2013	German-Catalan workshop on epigenetics and cancer.
4/2013	Genetic syndromes caused by mutations in epigenetic genes.
11/2011	Bivalent histone modifications in stem cells poise miRNA loci for CpG island hypermethylation in human cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manel Esteller Research Topics

Disease

240	Neoplasms (Cancer) 12/2022 - 01/2002
40	Breast Neoplasms (Breast Cancer) 02/2021 - 04/2003
30	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2002
29	Carcinogenesis 01/2021 - 09/2003
17	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2005
15	Lung Neoplasms (Lung Cancer) 06/2020 - 07/2002
13	Carcinoma (Carcinomatosis) 01/2019 - 11/2002
12	Rett Syndrome (Rett's Disorder) 03/2022 - 01/2005
10	Hematologic Neoplasms (Hematological Malignancy) 11/2022 - 10/2003
10	Leukemia 06/2020 - 08/2004
10	Colonic Neoplasms (Colon Cancer) 01/2020 - 09/2003
8	Microsatellite Instability 04/2021 - 02/2002
8	Inflammation (Inflammations) 01/2021 - 08/2004
8	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 11/2009
6	Melanoma (Melanoma, Malignant) 04/2021 - 11/2005
6	Triple Negative Breast Neoplasms 01/2021 - 11/2016
6	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 04/2003
6	Genomic Instability 11/2017 - 04/2005
6	Lymphoma (Lymphomas) 05/2013 - 12/2002
5	Atherosclerosis 01/2022 - 07/2004
5	Glioma (Gliomas) 01/2022 - 08/2004
5	Prostatic Neoplasms (Prostate Cancer) 06/2020 - 02/2005
5	Adenocarcinoma of Lung 01/2020 - 07/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2011
5	Adenocarcinoma 01/2020 - 08/2004
5	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 09/2004
5	Neuroblastoma 01/2012 - 08/2004
4	Nervous System Diseases (Neurological Disorders) 08/2021 - 11/2009
3	Atherosclerotic Plaque (Atheroma) 01/2022 - 02/2015
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2021 - 10/2003
3	Obesity 01/2021 - 01/2016
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 09/2020 - 03/2006
3	Fibrosis (Cirrhosis) 01/2020 - 04/2008
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 08/2004
3	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2018 - 01/2015
3	Adenoma (Adenomas) 01/2018 - 12/2008
3	Hyperplasia 02/2016 - 04/2003
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 06/2015 - 09/2004
3	Werner Syndrome (Werner's Syndrome) 01/2015 - 07/2007
3	Glioblastoma (Glioblastoma Multiforme) 03/2014 - 04/2007
2	Hypersensitivity (Allergy) 12/2022 - 01/2020
2	Stroke (Strokes) 10/2022 - 03/2020
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 01/2017
2	Polyps 01/2022 - 09/2020
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2021 - 09/2006

Drug/Important Bio-Agent (IBA)

80	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2002
58	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2003
51	Proteins (Proteins, Gene)FDA Link 10/2022 - 12/2002
44	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2007
29	Histones (Histone)IBA 01/2020 - 08/2004
24	MethyltransferasesIBA 01/2022 - 01/2002
22	RNA (Ribonucleic Acid)IBA 12/2022 - 09/2007
20	Pharmaceutical PreparationsIBA 01/2022 - 08/2004
18	ChromatinIBA 10/2022 - 01/2002
17	EnzymesIBA 04/2021 - 08/2003
16	Messenger RNA (mRNA)IBA 01/2022 - 12/2002
15	Biological ProductsIBA 11/2022 - 06/2003
13	A-Form DNA (A-DNA)IBA 11/2020 - 08/2003
11	hydrogen sulfite (bisulfite)IBA 01/2022 - 01/2005
11	Transcription Factors (Transcription Factor)IBA 01/2021 - 08/2003
10	Long Noncoding RNAIBA 01/2022 - 06/2012
9	Cadherins (E-Cadherin)IBA 02/2016 - 02/2003
7	5-Methylcytosine (5 Methylcytosine)IBA 12/2019 - 08/2002
7	beta CateninIBA 09/2008 - 11/2002
6	Protein Isoforms (Isoforms)IBA 01/2021 - 07/2015
6	Phenobarbital (Luminal)FDA Link 10/2019 - 09/2008
6	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 10/2010
6	Histone Deacetylases (Histone Deacetylase)IBA 04/2013 - 08/2004
5	Carrier Proteins (Binding Protein)IBA 11/2019 - 12/2003
5	O-(6)-methylguanineIBA 10/2019 - 01/2002
5	Lysine (L-Lysine)FDA Link 01/2018 - 08/2004
5	Decitabine FDA Link 05/2015 - 03/2003
5	Histone Deacetylase InhibitorsIBA 02/2009 - 10/2003
5	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2005 - 08/2002
4	Cyclin D1IBA 01/2021 - 11/2002
4	ParaffinIBA 01/2020 - 12/2008
4	CytokinesIBA 11/2019 - 04/2003
4	PlatinumIBA 01/2016 - 10/2012
4	Methyl-CpG-Binding Protein 2IBA 09/2014 - 01/2007
4	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2004 - 08/2002
3	InterferonsIBA 04/2021 - 11/2017
3	Cell-Free Nucleic AcidsIBA 02/2021 - 01/2018
3	CytosineIBA 01/2021 - 04/2008
3	GuanineIBA 01/2021 - 08/2007
3	ProteomeIBA 01/2020 - 04/2014
3	Docetaxel (Taxotere)FDA Link 10/2019 - 01/2017
3	Apolipoproteins E (ApoE)IBA 01/2019 - 07/2004
3	ApolipoproteinsIBA 01/2018 - 07/2004
3	Untranslated RNA (Noncoding RNA)IBA 01/2018 - 04/2013
3	Calcibiotic Root Canal SealerIBA 01/2017 - 02/2002
3	Estrogen ReceptorsIBA 05/2014 - 02/2005
3	DNA Repair EnzymesIBA 04/2013 - 01/2002
3	Complementary DNA (cDNA)IBA 04/2005 - 06/2004
3	gamma Catenin (Plakoglobin)IBA 08/2003 - 11/2002
2	Circular RNAIBA 03/2022 - 06/2018

Therapy/Procedure

48	Therapeutics 11/2022 - 02/2003
15	Drug Therapy (Chemotherapy) 01/2018 - 10/2003
7	Immunotherapy 01/2022 - 01/2018
7	Precision Medicine 02/2021 - 07/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2022 - 08/2021